Health and wellness company The Calmer Co. International Limited (ASX:CCO) has launched a new product, Noble Focus, online via www.fijikava.com.
Highlights
- Noble Focus is a synergistic combination providing calm, focus and memory enhancement utilising our proprietary Noble Kava water extract with Brahmi (Bacopa monnieri) extract.
- Kava extract has been shown in multiple clinicals trial to reduce anxiety symptoms while Brahmi has been shown to support memory, concentration and learning function.
- Noble Focus is targeting the US$4.6 billion Nootropics market which has grown at 17% in 2023 and includes executives looking for an edge, e-Sports Athletes and students seeking to improve memory and recall when studying.
- Launch on the Australia www.fijikava.com Shopify site to be followed by global rollout. The product will also be rolled out to China, USA and the Pacific markets in the coming months pending regulatory approvals.
Many kava users have reported improved concentration when kava products are consumed at a low dose. Reducing the noise of a busy mind, one might say,” The Calmer Co. CEO, Anthony Noble, said.
“We formulated Noble Focus with a low dose of kava alongside Brahmi which itself not only improves memory and recall, but also provides calm, clear focus. Evidence shows it can reduce nervous tension and mild anxiety too.
“So, this product is a truly synergistic formula, and suitable for use at any time of day to deliver Nootropic benefits. It is our first product designed for daytime use and high performance.”
